Cannara Biotech Achieves Its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024
Cannara Biotech Achieves Its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024
MONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that the Company has achieved its highest national market share of 3.2% in July 2024 which places Cannara as the 9th largest licensed producer in Canada by market share1.
蒙特利爾,2024年8月16日(環球社交媒體) - 大麻股Cannara Biotech Inc.(「Cannara」或「公司」)(TSXV:LOVE)(OTCQB:LOVFF)(FRA:8CB0)是一家垂直一體化生產優質大麻和衍生產品的公司,以負擔得起的價格在魁北克擁有兩個超級大廠房,總面積超過165萬平方英尺。 今天宣佈,公司已在2024年7月取得3.2%的最高全國市場份額,成爲加拿大第九大有許可的生產商。
"We are thrilled to report that July 2024 marks a significant milestone for Cannara, with our highest monthly national retail sales in the Company's history, including an approximate 11.8% market share in Quebec1. This achievement is a testament to the dedication and hard work of our entire team, as well as the growing demand for our premium cannabis products. We look forward to discussing these results in more detail during our upcoming investor webcast, where we will provide further insights into our third quarter of 2024 financial performance and future growth strategies," commented Nicholas Sosiak, CFO of Cannara.
「我們非常高興地報告說,2024年7月是Cannara的一個重要里程碑,我們在公司歷史上取得了最高月銷售額,包括魁北克省約11.8%的市場份額。這一成就證明了我們整個團隊的奉獻和勤奮工作,以及我們優質大麻產品不斷增長的需求。我們期待在即將到來的投資者網絡研討會中更詳細地討論這些結果,屆時我們將提供有關2024年第三季度財務業績和未來增長策略的進一步見解,」Cannara的首席財務官尼古拉斯·索西亞克評論道。
Cannara will host a live investor webcast on Tuesday, August 20, 2024, at 2:00 PM ET. Nicholas Sosiak, CFO, will lead the presentation, covering key aspects of the business and delivering a detailed update on Q3 2024 financial results. Following the presentation, investors will have the opportunity to participate in an interactive Q&A session.
Cannara將於2024年8月20日(星期二)下午2:00舉辦現場投資者網絡研討會。首席財務官尼古拉斯·索西亞克將主持演示,重點介紹業務的關鍵方面,並詳細更新2024年第三季度的財務業績。演示後,投資者將有機會參加互動問答環節。
Date & Time: August 20, 2024, at 2:00 PM ET
Webcast Link:
日期和時間:2024年8月20日,東部時間下午2:00
網絡廣播鏈接:
To listen to the webcast or participate in the live Q&A, please pre-register using the link provided above.
要收聽網絡研討會或參加實時問答,請使用上面提供的鏈接進行預註冊。
For those unable to attend the live event, an archived version of the webcast and presentation will be available on the Company's investor relations website at .
對於無法參加現場活動的人,網絡研討會和演示的存檔版本將在公司的投資者關係網站上提供。
Contact:
Brian Siegel,IRC,MBA-高級管理董事,Hayden IR,電話:(346)396-8696,ir@zedge.net
Nicholas Sosiak, CPA, CA
Chief Financial Officer
nicholas.sosiak@cannara.ca
尼古拉斯·索西亞克,註冊會計師(加拿大),特許會計師(美國)
致富金融(臨時代碼)
nicholas.sosiak@cannara.ca
Zohar Krivorot
President & Chief Executive Officer
zohar.krivorot@cannara.ca
Zohar Krivorot
董事長兼首席執行官
zohar.krivorot@cannara.ca
About Cannara Biotech Inc.
關於Cannara Biotech Inc。
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec's low electricity costs, Cannara's facilities produce premium-grade cannabis products at an affordable price. For more information, please visit a.ca.
Cannara Biotech Inc.(TSXV:LOVE)(OTCQB:LOVFF)(FRA:8CB0)是爲加拿大市場提供負擔得起的優質大麻和大麻衍生產品的垂直一體化生產商。 Cannara擁有位於魁北克省的兩個超級大廠房,總面積超過165萬平方英尺,可爲公司提供10萬公斤的潛在年化種植產量。藉助魁北克低廉的電力成本,Cannara的設施以實惠的價格生產優質的大麻產品。有關更多信息,請訪問 a.ca.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
TSX 創業板塊交易所和其監管服務提供商(如 TSX 創業板塊政策中所定義的)均不承擔本公告的充分性或準確性責任。
Cautionary Statement Regarding "Forward-Looking" Information
關於「前瞻性」信息的警告聲明
This information release contains certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
本信息發佈包含某些前瞻性信息。這樣的信息涉及已知和未知的風險、不確定性和其他因素,這些因素可能導致實際結果、績效或業績與此處所述的陳述有實質性的不同,因此這些陳述不應被視爲未來績效或結果的保證。所有前瞻性陳述均基於公司當前的信仰以及它作出的假設和目前可用的信息以及其他因素。讀者被警告不要過於依賴這些前瞻性陳述,這些陳述只有發佈日期爲準。由於風險和不確定性,包括公司在其公開證券備案中所確定的風險和不確定性,實際事件可能與當前預期有實質性不同。公司不承擔任何意向或義務更新或修訂任何前瞻性陳述,無論是因爲新增信息、未來事件還是其他原因。
1 Based on estimated sales data provided by HiFyre Retail Analytics, Licensed Producer Sales Nationally, for the period of July 2024.
1 根據HiFyre零售分析提供的估計銷售數據,包括2024年7月的全國許可製造商銷售額。